title: Effect of medical expulsive therapy on the health-related quality of life of patients with ureteral stones: a critical evaluation.
abstract: OBJECTIVE
  To evaluate the possible effects of medical expulsive therapy (MET) on the health-related quality of life (HRQOL) of the patients under watchful waiting for ureteral stones.
  
  
  METHODS
  A total 120 patients with ureteral stones were included into this study program. Patients were divided into two subgroups. While patients in group 1 received medical therapy only for colic pain if needed, patients in group 2 received MET (tamsulosin 0.4 mg/once daily) in addition to medical therapy. All cases were evaluated weekly during 1-month period, and the patients with persistent stones after this period in both groups were evaluated with respect to the analgesic requirement, number of renal colic attacks as well as emergency department (ED) visits along with the QOL scores.
  
  
  RESULTS
  Mean values of patient age and stone burden were 37.14 ± 2.46 years and 42.04 ± 2.03 mm(2), respectively. Evaluation of the cases with residing stones after 4 weeks (28 cases in group 1 and 27 cases in group 2) with or without MET revealed following findings; renal colic, total amount of analgesic required and the mean number of ED visits were significantly lower in cases receiving MET. Evaluation of the mean HRQOL in terms of EQ-5D index and EQ-5D VAS values in both groups again demonstrated higher mean values in patients undergoing MET (p < 0.05).
  
  
  CONCLUSIONS
  Our findings indicated that MET for ureteral calculi during watchful waiting period could increase the HRQOL scores by lowering the number of both renal colic attacks and ED visits resulting in decreased analgesic need.
authors.affiliation: Department of Urology, Dr. Lutfi Kırdar Research and Training Hospital, Istanbul, Turkey.
authors.forename: Bilal
authors.initials: B
authors.lastname: Eryildirim
authors.forename: Cahit
authors.initials: C
authors.lastname: Sahin
authors.forename: Murat
authors.initials: M
authors.lastname: Tuncer
authors.forename: Kubilay
authors.initials: K
authors.lastname: Sabuncu
authors.forename: Cihangir
authors.initials: C
authors.lastname: Cetinel
authors.forename: Fatih
authors.initials: F
authors.lastname: Tarhan
authors.forename: Kemal
authors.initials: K
authors.lastname: Sarica
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004636:Emergency Service, Hospital / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D006304:Health Status; D006801:Humans; D008297:Male; D009819:Office Visits / Q000706:statistics & numerical data; D011379:Prognosis; D011788:Quality of Life; D056844:Renal Colic / Q000188:drug therapy* / Q000209:etiology; D012189:Retrospective Studies; D013449:Sulfonamides / Q000627:therapeutic use; D000077409:Tamsulosin; D014514:Ureteral Calculi / Q000150:complications / Q000188:drug therapy / Q000523:psychology*; D057832:Watchful Waiting / Q000379:methods*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D000700:Analgesics; D013449:Sulfonamides; D000077409:Tamsulosin